![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Phase Scientific’s COVID-19 Test Gets Emergency Use Authorization from FDA
Phase Scientific’s COVID-19 Test Gets Emergency Use Authorization from FDA
The FDA has granted an Emergency Use Authorization to Phase Scientific International’s Indicaid COVID-19 rapid antigen at-home test.
The Garden Grove, Calif.-based company’s over-the-counter test for home use is intended for the qualitative detection of antigen from the SARS-CoV-2 coronavirus that causes COVID-19 infection.
The test uses self-collected anterior nasal swab samples from people age 14 and up or samples collected by an adult from a child age two to 13. The test is intended for use within six days of the onset of symptoms.
Upcoming Events
-
21Oct